Targeting DNA Repair in Prostate Cancer

被引：4
作者：
Abida, Wassim [1 ]
Sawyers, Charles L. [1 ,2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 10期
关键词：
INCREASED SURVIVAL; ORGANOID CULTURES; EWINGS-SARCOMA; CHEMOTHERAPY; OLAPARIB; CELLS; IDENTIFICATION; ENZALUTAMIDE; SENSITIVITY; ABIRATERONE;
D O I：
10.1200/JCO.2017.76.6592
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1017 / +
页数：5
相关论文
共 50 条
  • [41] Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer
    Annala, Matti
    Struss, Werner J.
    Warner, Evan W.
    Beja, Kevin
    Vandekerkhove, Gillian
    Wong, Amanda
    Khalaf, Daniel
    Seppala, Irma-Liisa
    So, Alan
    Lo, Gregory
    Aggarwal, Rahul
    Small, Eric J.
    Nykter, Matti
    Gleave, Martin E.
    Chi, Kim N.
    Wyatt, Alexander W.
    EUROPEAN UROLOGY, 2017, 72 (01) : 34 - 42
  • [42] Targeting DNA repair proteins: A promising avenue for cancer gene therapy
    Belzile, JP
    Choudhury, SA
    Cournoyer, D
    Chow, TYK
    CURRENT GENE THERAPY, 2006, 6 (01) : 111 - 123
  • [43] Aberrations of DNA repair pathways in prostate cancer: a cornerstone of precision oncology
    Boussios, Stergios
    Rassy, Elie
    Shah, Sidrah
    Ioannidou, Evangelia
    Sheriff, Matin
    Pavlidis, Nicholas
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (05) : 329 - 333
  • [44] Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
    Lin, Hui-Ming
    Mak, Blossom
    Yeung, Nicole
    Huynh, Kevin
    Meikle, Thomas G.
    Mellett, Natalie A.
    Kwan, Edmond M.
    Fettke, Heidi
    Tran, Ben
    Davis, Ian D.
    Mahon, Kate L.
    Zhang, Alison
    Stockler, Martin R.
    Briscoe, Karen
    Marx, Gavin
    Crumbaker, Megan
    Stricker, Phillip D.
    Du, Pan
    Yu, Jianjun
    Jia, Shidong
    Scheinberg, Tahlia
    Fitzpatrick, Michael
    Bonnitcha, Paul
    Sullivan, David R.
    Joshua, Anthony M.
    Azad, Arun A.
    Butler, Lisa M.
    Meikle, Peter J.
    Horvath, Lisa G.
    EBIOMEDICINE, 2021, 72
  • [45] Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic
    Ghose, Aruni
    Moschetta, Michele
    Pappas-Gogos, George
    Sheriff, Matin
    Boussios, Stergios
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [46] Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer
    Archer, Maddison
    Begemann, Diane
    Gonzalez-Kozlova, Edgar
    Nepali, Prerna R.
    Labanca, Estefania
    Shepherd, Peter
    Dogra, Navneet
    Navone, Nora
    Kyprianou, Natasha
    MOLECULAR CANCER RESEARCH, 2024, 22 (08) : 730 - 745
  • [47] New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer
    Assi, Rita
    Temraz, Sally
    Shamseddine, Ali
    Mukherji, Deborah
    CURRENT DRUG TARGETS, 2016, 17 (03) : 290 - 302
  • [48] Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer
    Lin, Jian-Zhong
    Wang, Zeng-Jun
    De, Wei
    Zheng, Ming
    Xu, Wei-Zhang
    Wu, Hong-Fei
    Armstrong, Alex
    Zhu, Jia-Geng
    ONCOTARGET, 2017, 8 (25) : 41064 - 41077
  • [49] Small molecules, inhibitors of DNA-PK, targeting DNA repair, and beyond
    Davidson, David
    Amrein, Lilian
    Panasci, Lawrence
    Aloyz, Raquel
    FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [50] Computational Modeling to Identify Drugs Targeting Metastatic Castration-Resistant Prostate Cancer Characterized by Heightened Glycolysis
    Su, Mei-Chi
    Lee, Adam M.
    Zhang, Weijie
    Maeser, Danielle
    Gruener, Robert F.
    Deng, Yibin
    Huang, R. Stephanie
    PHARMACEUTICALS, 2024, 17 (05)
12345